What does this research mean for the field?

Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to evaluate the role of neuronal PPP2R5C in plasma as an early biomarker for Alzheimer’s disease.

February 22, 2026Open Access

Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease

Key Result

Neuronal PPP2R5C detected in plasma shows potential as a biomarker for early diagnosis of Alzheimer's disease.

Key Points

The aim is to evaluate the role of neuronal PPP2R5C in plasma as an early biomarker for Alzheimer’s disease.
Analysis of plasma levels of PPP2R5C in individuals with early-stage Alzheimer's disease.
Comparative evaluation with control subjects.
Statistical correlation of PPP2R5C levels with cognitive decline indicators.
Higher levels of PPP2R5C were detected in participants with early Alzheimer's compared to controls.
The presence of PPP2R5C correlated significantly with cognitive impairment scores.
Identifying PPP2R5C as a potential early diagnostic marker for Alzheimer's disease.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Read Full Paperexternally

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Luo et al. (Sun,) reported a other. Neuronal PPP2R5C detected in plasma shows potential as a biomarker for early diagnosis of Alzheimer's disease.

synapsesocial.com/papers/699a9ceb482488d673cd296a https://doi.org/https://doi.org/10.1016/j.xcrm.2026.102631